The information referred to in Article 33(2) of this Regulation and the information on the status of a unique identifier should stay accessible to all parties required to verify the authenticity of medicinal products, as such information is necessary for the proper performing of those verifications.
Recital 38, Regulation (EU) 2016/161
In forcesince 2 Oct 2015